Health-economic comparison of paricalcitol, calcitriol and Alfacalcidol for the treatment of secondary hyperparathyroidism during haemodialysis

被引：0
|
作者：
Fiedler, Roman [1 ]
机构：
[1] Univ Halle Wittenberg, Dept Nephrol, Halle, Germany
来源：
CLINICAL DRUG INVESTIGATION | 2007年 / 27卷 / 12期
关键词：
Secondary Hyperparathyroidism; Alfacalcidol; Active Vitamin; National Kidney Foundation; Paricalcitol;
D O I：
10.2165/00044011-200727120-00010
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：865 / 866
页数：2
相关论文
共 50 条
  • [1] Health-economic comparison of paricalcitol, calcitriol and alfacalcidol for the treatment of secondary hyperparathyroidism during haemodialysis
    Rosery, Hubertus
    Bergemann, Rito
    Marx, Steven E.
    Boehnke, Axel
    Melnick, Joel
    Sterz, Raimund
    Williams, Laura
    CLINICAL DRUG INVESTIGATION, 2006, 26 (11) : 629 - 638
  • [2] Health-Economic Comparison of Paricalcitol, Calcitriol and Alfacalcidol for the Treatment of Secondary Hyperparathyroidism during Haemodialysis
    Hubertus Rosery
    Rito Bergemann
    Steven E. Marx
    Axel Boehnke
    Joel Melnick
    Raimund Sterz
    Laura Williams
    Clinical Drug Investigation, 2006, 26 : 629 - 638
  • [3] Health-Economic Comparison of Paricalcitol, Calcitriol and Alfacalcidol for the Treatment of Secondary Hyperparathyroidism during Haemodialysis
    Roman Fiedler
    Clinical Drug Investigation, 2007, 27 : 865 - 866
  • [4] Treatment of secondary hyperparathyroidism in haemodialysis patients: a randomised clinical trial comparing paricalcitol and alfacalcidol
    Ditte Hansen
    Lisbet Brandi
    Knud Rasmussen
    BMC Nephrology, 10
  • [5] Treatment of secondary hyperparathyroidism in haemodialysis patients: a randomised clinical trial comparing paricalcitol and alfacalcidol
    Hansen, Ditte
    Brandi, Lisbet
    Rasmussen, Knud
    BMC NEPHROLOGY, 2009, 10
  • [6] Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism
    Sprague, SM
    Llach, F
    Amdahl, M
    Taccetta, C
    Batlle, D
    KIDNEY INTERNATIONAL, 2003, 63 (04) : 1483 - 1490
  • [7] Randomized trial comparing pulse calcitriol and alfacalcidol for the treatment of secondary hyperparathyroidism in haemodialysis patients
    Kiattisunthorn, Kraiwiporn
    Wutyam, Kittikarn
    Indranoi, Artit
    Vasuvattakul, Somkiat
    NEPHROLOGY, 2011, 16 (03) : 277 - 284
  • [8] Intravenous calcitriol versus paricalcitol in haemodialysis patients with severe secondary hyperparathyroidism
    Gafor, Abdul Halim Abdul
    Saidin, Rashidi
    Yean, Loo Chee
    Mohd, Rozita
    Zainudin, Soehardy
    Shah, Shamsul Azhar
    Tong, Norella Kong Chiew
    NEPHROLOGY, 2009, 14 (05) : 488 - 492
  • [9] Changes in fibroblast growth factor 23 during treatment of secondary hyperparathyroidism with alfacalcidol or paricalcitol
    Hansen, Ditte
    Rasmussen, Knud
    Pedersen, Susanne M.
    Rasmussen, Lars M.
    Brandi, Lisbet
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (06) : 2263 - 2269
  • [10] Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism in hemodialysis patients.
    Rabinovich, MB
    Walton, T
    PHARMACOTHERAPY, 2005, 25 (10): : 1465 - 1465
12345